Nonfasting Sample for the Determination of Routine Lipid Profile: Is It an Idea Whose Time Has Come?

Affiliations

• ¹ Departments of Laboratory Medicine and Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA; nader.rifai@childrens.harvard.edu.
• ² Center for Public Health, Queen's University, Belfast, Northern Ireland;
• ³ Chair of the European Atherosclerosis Society/European Federation of Clinical Chemistry and Laboratory Medicine Expert Panel for the Development of Consensus Statement on Lipid Testing, Chief Physician in Clinical Chemistry, Copenhagen University Hospital, Clinical Professor, University of Copenhagen, Denmark;
• ⁴ Chair of the 2014 Lipids & Cardiovascular Risk Assessment Guideline Group at the National Institute of Health and Clinical Excellence, Professor and Director of the Lipid Unit, Guy's and St Thomas' Hospitals, London, UK;
• ⁵ Chief of the Protein Biomarker Lab, Centers for Disease Control and Prevention, Atlanta, GA;
• ⁶ Associate Physician in Cardiovascular and Preventive Medicine, Brigham and Women's Hospital, Associate Professor of Medicine, Harvard Medical School, Boston, MA;
• ⁷ Chair of the 2013 American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Bonow Professor of Medicine (preventive cardiology), Feinberg School of Medicine, Northwestern University, Chicago, IL;
• ⁸ Member of the 2012 Guidelines Expert Panel for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults of the Canadian Cardiovascular Society, Professor of Faculty of Medicine, McGill University, Montreal, Canada;
• ⁹ Professor of Pathology, Director of Clinical Chemistry Laboratory, Virginia Commonwealth University Health System, Richmond, VA.